New research published online-ahead-of-print in Journal of the National Comprehensive Cancer Network found that people with ...
Expanding Medicaid is associated with an increase in receipt of guideline-concordant treatment among nonelderly women newly ...
3d
The proportion is significantly higher than that estimated using the commonly used Body Mass Index (BMI). Researchers suggest ...
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug ...
Increased body fat elevates estrogen production, potentially fueling growth of hormone-positive breast cancers, researchers ...
Hormone therapy (also called hormonal therapy or endocrine therapy) slows or stops the growth of hormone-sensitive tumors by blocking the body’s ability to produce hormones or by interfering with the ...
About 40% of hormone-positive breast cancers in postmenopausal women might be linked to excess body fat, researchers reported ...
A nurse practitioner discusses ASCO’s recommendations of CDK4/6 inhibitors—namely abemaciclib and ribociclib—in certain ...
According to the American Cancer Society (ACS), about 2 out of every 3 cases of breast cancer are hormone receptor-positive. Most of these cases are ER-positive, meaning that there are estrogen ...
Excess body fat plays a role in postmenopausal hormone receptor-positive breast cancer, which could be underestimated using only body mass index (BMI). HealthDay News — Excess body fat plays a role in ...
This month, the NCCN Clinical Practice Guidelines in Oncology, NCCN Guidelines, for breast cancer were updated to recommend ribociclib as a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback